FDA issues recommendations on 510(k) reform and use of science in regulatory decision making
On August 4, 2010, the Food and Drug Administration (FDA or the Agency) issued its long-awaited recommendations on reform of the 510(k) process.
Morgan Lewis Advises on Venezuela-Related Legal and Regulatory Developments
Leadership changes in Venezuela are creating heightened geopolitical risk and business uncertainty for U.S. and multinational companies.
Morgan Lewis is closely monitoring developments and advising clients on how evolving conditions may affect Venezuela-related operations, risk exposure, opportunities, and strategic decision-making. Explore our Venezuela Global Capabilities webpage and read our LawFLash, "Compliance Landscape in Venezuela Following Nicolas Maduro’s Removal from Power."
At Morgan Lewis, we work collaboratively across practices and regions to help clients stay informed, assess risk, and respond effectively to changing legal and regulatory conditions.
Popular articles from this firm
